David M. Bender

Synthesis, Crystallization, and Biological Evaluation of an Orally Active Prodrug of Gemcitabine

David M. Bender, Jingqi Bao, Anne H. Dantzig et al. · Journal of Medicinal Chemistry · 2009 · 107 citations

Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Science +14

Synthesis of n.c.a. carbon-11 labelled clozapine and its major metabolite clozapine-N-oxide and comparison of their biodistribution in mice

David M. Bender, M. Holschbach, G. Stöcklin · Nuclear Medicine and Biology · 1994 · 85 citations

Medicinal Chemistry, Medicine, Psychotropic Medication +3

Mitsunobu Approach to the Synthesis of Optically Active α,α-Disubstituted Amino Acids

Jonathan E. Green, David M. Bender, Stona Jackson et al. · Organic Letters · 2009 · 78 citations

α-Disubstituted Amino Acids, Bioorganic Chemistry, Mitsunobu Reaction +13

Characterization of the Expression and Activity of Carboxylesterases 1 and 2 from the Beagle Dog, Cynomolgus Monkey, and Human

Eric T. Williams, James A. Bacon, David M. Bender et al. · Drug Metabolism and Disposition · 2011 · 71 citations

Synthesis and Pharmacological Characterization of 2-(2,6-Dichlorophenyl)-1-((1<i>S</i>,3<i>R</i>)-5-(3-hydroxy-3-methylbutyl)-3-(hydroxymethyl)-1-methyl-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)ethan-1-one (LY3154207), a Potent, Subtype Selective, and Orally Available Positive Allosteric Modulator of the Human Dopamine D1 Receptor

Junliang Hao, James P. Beck, John M. Schaus et al. · Journal of Medicinal Chemistry · 2019 · 56 citations · Full text

Pharmacological Characterization, Drug Target, Pharmacotherapy +21